ArticleFrontiers in endocrinology2026
Development and validation of a simplified pre-screening model for diabetic foot ulcer identification in diabetic patients.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to develop a simplified cross-sectional pre-screening tool for diabetic foot ulcer (DFU) using routinely available clinical indicators, with particular focus on the albumin-to-glycated hemoglobin ratio (Alb/HbA1c) as a composite marker of nutritional status and glycemic control. Methods: We retrospectively analyzed 1,854 hospitalized patients with type 2 diabetes (training set, January 2012-December 2020) and 678 outpatients (validation set, January 2021-December 2025) from a geographically distinct branch of the same hospital system. Demographic characteristics, lifestyle factors, and laboratory parameters were collected. LASSO regression and multivariate logistic regression were used for predictor selection. Model performance was assessed by area under the curve (AUC), calibration curves, Hosmer-Lemeshow test, and Brier score. Risk was visualized using nomograms and heatmaps. Results: DFU prevalence was 20.9% in the training set and 15.8% in the validation set. Four independent predictors were identified: age (OR = 1.029/year), history of injury (OR = 7.57), alcohol consumption (OR = 0.48, see Discussion for interpretation), and Alb/HbA1c ratio (OR = 0.49). The model showed good discrimination in the training (AUC 0.807, 95% CI 0.790-0.825) and validation sets (AUC 0.817, 95% CI 0.782-0.852), with acceptable calibration (Hosmer-Lemeshow P > 0.05; Brier scores 0.127 and 0.118). Internal validation confirmed stability (optimism-corrected AUC = 0.803). Risk heatmaps revealed synergistic interactions between age and Alb/HbA1c, with injury history amplifying risk across all strata. Conclusion: This simplified pre-screening model using age, injury history, alcohol consumption, and Alb/HbA1c demonstrates a high negative predictive value, making it suitable for ruling out DFU in resource-limited primary care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.